Detection of latent tuberculosis infection using the Enzym-Linked ImmunoSpot technique

Detection of latent tuberculosis infection using ELISPOT - Detection of latent tuberculosis infection using ELISPOT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON58430

Enrollment

Registered

2026-03-02

Start date

2026-04-15

Completion date

Unknown

Last updated

2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis, latent tuberculosis, M. tuberculosis, TB Tuberculosis

Interventions

Diagnostic value of the T-SPOT.TB test and the TB IP-10 test compared with QuantiFERON GOLD PLUS.

Eligibility

Inclusion criteria

Inclusion criteria: Patients scheduled to initiate biological therapy, for whom latent tuberculosis infection must be excluded prior to treatment.

Exclusion criteria

Exclusion criteria: Patients aged <18 years.

Design outcomes

Primary

Measure	Time frame
ELISPOT: Spot forming units.IP-10: Positive / negative IP-10 result.	—

Secondary

Measure	Time frame
nvt	—

Countries

Netherlands

Contacts

Public ContactD.A.T. Hanssen

Maastricht Universitair Medisch Centrum +

danielle.hanssen@mumc.nl043 3876644

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026